Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

Go back to Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
(NASDAQ: WVE) Delayed: 3.40 +0.03 (0.89%)
Previous Close $3.37    52 Week High $38.50 
Open $3.36    52 Week Low $8.95 
Day High $3.43    P/E N/A 
Day Low $3.35    EPS $0.00 
Volume 361,984